Johns Hopkins Diabetes GuideClinical TestsGlucose Monitoring

Hemoglobin A1c

Thomas Donner, M.D., Christopher Saudek, M.D.
Hemoglobin A1c is a topic covered in the Johns Hopkins Diabetes Guide.

To view the entire topic, please or purchase a subscription.

Johns Hopkins Guides provide diagnosis, management, and treatment guidance for infectious diseases, diabetes, and psychiatric conditions. Explore these free sample topics:

Johns Hopkins Guides

~~ The first section of this topic is shown below ~~

DESCRIPTION

  • Hemoglobin A1c (HbA1c) is a stable adduct of glucose on the beta-chain of hemoglobin (N-[1-deoxyfructosyl]hemoglobin).
  • Formed by a largely irreversible reaction, post-translationally and non-enzymatically, when hemoglobin circulating in a red blood cell is exposed to ambient glucose
  • Alternate terms: "A1c" (preferred for use in communication with patients), "glycated hemoglobin" (the most accurate term), glycosylated hemoglobin.
  • Expressed most often as the percent of hemoglobin that is glycated (alternatively, as mmol glycated hemoglobin per mole total hemoglobin).
  • The single best test to monitor overall blood glucose control in diabetes [5]
  • Reflects the average blood glucose over about 3 months previously, although somewhat disproportionately weighted to recent blood glucose levels [6]
  • A strong indicator of risk for long-term diabetic complications, especially retinopathy, neuropathy and nephropathy (DCCT).
  • Also an indicator of cardiovascular disease (CVD) risk, although glucose control is less strong of a risk factor for CVD than lipids, blood pressure and smoking [4]
  • Recently, HbA1c > 6.5% is recommended as a criterion for diagnosing diabetes [8] [13].

~~ To view the remaining sections of this topic, please
or purchase a subscription ~~

Last updated: July 31, 2016